|
⚲
|
| Lead Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001400100 |
| Sale | 2009-04-28 ($7.0 M Offered, $3.0 M Sold) |
| Fund | |
| Phone | 6507371630 |
| Address | 999 Bayhill Drive, Suite 130 San Bruno, 94066 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Shuang Qiao | |
| Alain Schreiber | |
| Leonard Post | |
| Peter Myers | |
| Arthur Pappas | |
| David Hanabusa |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Asymmetria Investors III, LLC - Aeromed (PS)
✚
|
0.0 | |
|
Asymmetria Investors III, LLC - AFFF (PS)
✚
|
0.0 | |
|
Asymmetria Investors III, LLC - EGAP Fund II Add-On (PS)
✚
|
0.0 | |
|
Asymmetria Investors III, LLC - Forte (PS)
✚
|
0.0 | |
|
A-TEW-13-Fund, a series of AX-JaGi-Funds, LLC
✚
|
0.0 | |
|
Athayde Amanda
✚
|
0.0 | |
|
Athens Buligo LP
✚
|
0.0 | |
|
Atkinson Robert D
✚
|
0.0 | |
|
ATL 105 LLC
✚
|
0.0 | |
|
Asymmetria Investors III, LLC - ACI Fund III (PS)
✚
|
0.0 |